Auransa Inc. is a clinical-stage, AI-native biopharmaceutical company based in Palo Alto, California, founded in 2014 by Pek Lum. Auransa uses its proprietary SMarTR Engine — a hypothesis-free machine learning platform that mines human disease data such as RNA transcriptome and gene-expression profiles — to discover novel small-molecule… - View it on GitHub